The efficacy of fluorocarbon, surfactant, and their combination for improving acute lung injury induced by intratracheal acidified infant formula

Anesthesia and Analgesia

Volumn 100, Issue 4, 2005, Pages 964-971

  Nishina, Kahoru ^a   Mikawa, Katsuya ^a   Takao, Yumiko ^a   Obara, Hidefumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROCARBON; FLUOROCARBON 84; LUNG SURFACTANT; SUPEROXIDE; SURFACTANT TA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MILK; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HISTOLOGY; LIQUID VENTILATION; LUNG EDEMA; LUNG MECHANICS; LUNG SEQUESTRATION; MALE; NEUTROPHIL; NONHUMAN; OXYGENATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME;

ACIDS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMILUMINESCENT MEASUREMENTS; DAIRY PRODUCTS; DRUG THERAPY, COMBINATION; FLUOROCARBONS; HEMODYNAMIC PROCESSES; HUMANS; INFANT FOOD; INFANT, NEWBORN; LEUKOCYTES; LUNG DISEASES; MALE; PNEUMONIA, ASPIRATION; PULMONARY EDEMA; PULMONARY GAS EXCHANGE; RABBITS; RESPIRATORY FUNCTION TESTS; SURFACE-ACTIVE AGENTS;

EID: 15544384906     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000146438.87584.A9     Document Type: Article

References (25)

1. O'Hare B, Lerman J, Endo J, Cutz E. Acute lung injury after instillation of human breast milk or infant formula into rabbits' lungs. Anesthesiology 1996;84:1386-91.
2. Nishina K, Mikawa K, Takao Y, et al. Effects of exogenous surfactant on acute lung injury induced by intratracheal instillation of infant formula or human breast milk in rabbits. Anesthesiology 1999;91:240-52.
3. Mikawa K, Nishina K, Takao Y, Obara H. Efficacy of partial liquid ventilation in improving acute lung injury induced by intratracheal acidified infant formula: Determination of optimal dose and positive end-expiratory pressure level. Crit Care Med 2004;32:209-16.
4. Mrozek JD, Smith KM, Bing DR, et al. Exogenous surfactant and partial liquid ventilation: physiologic and pathologic effects. Am J Respir Crit Care Med 1997;156:1058-65.
5. Weiswasser J, Lueders M, Stolar CJ. Pressure- versus volume-cycled ventilation in liquid-ventilated neonatal piglet lungs. J Pediatr Surg 1998;33:1158-62.
6. Chin C, O'Hare B, Lerman J, Endo J. Comparison of exogenous surfactant and positive end-expiratory pressure therapies in a model of human breast milk-induced acute lung injury in rabbits. Br J Anaesth 2000;84:600-7.
7. Ferreyra G, Goddon S, Fujino Y, Kacmarek RM. The relationship between gas delivery patterns and the lower inflection point of the pressure-volume curve during partial liquid ventilation. Chest 2000;117:191-8.
8. Huang YC, Caminiti SP, Fawcett TA, et al. Natural surfactant and hyperoxic lung injury in primates. I. Physiology and biochemistry J Appl Physiol 1994;76:991-1001.
9. Waugh JB, Op't-Holt TB, Olson LE, et al. Surfactant treatment impairs gas exchange in a canine model of acute lung injury. Crit Care Med 2000;28:2887-92.
10. Verbrugge SJ, Gommers D, Lachmann B. Conventional ventilation modes with small pressure amplitudes and high positive end-expiratory pressure levels optimize surfactant therapy. Crit Care Med 1999;27:2724-8.
11. Nakagawara K, Hirokata Y, Yoshitake J. Effects of anesthetics on superoxide releasing activity of human polymorphonuclear leukocytes. Jpn J Anesthesiol 1985;34:754-9.
12. Nishina K, Akamatsu H, Mikawa K, et al. The effects of clonidine and dexmedetomidine on human neutrophil functions. Anesth Analg 1999;88:452-8.
13. Mikawa K, Nishina K, Takao Y, Obara H. Intratracheal application of recombinant surfactant protein-C surfactant to rabbits attenuates acute lung injury induced by intratracheal acidified infant formula. Anesth Analg 2004;98:1273-9.
14. Kennedy TP, Johnson KJ, Kunkel RG, et al. Acute acid aspiration lung injury in the rat: Diphasic pathogenesis. Anesth Analg 1989;69:87-92.
15. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993;147:218-33.
16. Seeger W, Gnther A, Walmrath HP, et al. Alveolar surfactant and adult respiratory distress syndrome: Pathogenetic role and therapeutic prospects. Clin Investig 1993;71:177-90.
17. Ryan SF, Ghassibi Y, Liau DF. Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am J Respir Cell Mol Biol 1991;4:33-41.
18. Hartog A, Vazquez-de-Anda GF, Gommers D, et al. Comparison of exogenous surfactant therapy, mechanical ventilation with high end-expiratory pressure and partial liquid ventilation in a model of acute lung injury. Br J Anaesth 1999;82:81-6.
19. Leach CL, Holm B, Morin FC 3rd, et al. Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant. J Pediatr 1995;126: 412-20.
20. Merz U, Kellinghaus M, Hausler M, et al. Partial liquid ventilation with surfactant: Effects on gas exchange and lung pathology in surfactant-depleted piglets. Intensive Care Med 2000;26: 109-16.
21. Wolfson MR, Kechner NE, Roache RF, et al. Perfluorochemical rescue after surfactant treatment: Effect of perflubron dose and ventilatory frequency. J Appl Physiol 1998;84:624-40.
22. Tarczy-Hornoch P, Hildebrandt J, Mates EA, et al. Effects of exogenous surfactant on lung pressure-volume characteristics during liquid ventilation. J Appl Physiol 1996;80:1764-71.
23. Steinhorn DM, Leach CL, Fuhrman BP, Holm BA. Partial liquid ventilation enhances surfactant phospholipid production. Crit Care Med 1996;24:1252-6.
24. Mrozek JD, Smith KM, Simonton SC, et al. Perfluorocarbon priming and surfactant: Physiologic and pathologic effects. Crit Care Med 1999;27:1916-22.
25. Kristof AS, Goldberg P, Laubach V, Hussain SN. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998;158:1883-9.